Microbot Medical (Nasdaq:MBOT) today announced the full market release of its Liberty endovascular surgical robot in the U.S.

Microbot Medical Inc. announced that it has executed a limited market release of the Liberty robotic system for peripheral ...

Being Published in the Journal of Vascular and Interventional Radiology, a Premier Peer-Reviewed Journal, Speaks to the Quality and Impact of the Study Company Remains Focused on Expanding ...

Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular Space HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot ...

Includes Adoption by Globally Recognized Healthcare Systems in the U.S. Market and Demonstrates Broad Market Scalability in ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advancements and Future Role of Endovascular Robotics ...

Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It ...

HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that Harel Gadot, CEO, ...

HINGHAM, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, which is already garnering medical ...